Dividends & Buybacks ·
At its Ordinary General Shareholders' Meeting on June 18, 2026, Grifols, S.A. approved a mandatory preferred dividend…
GRFSGrifols SA
At its Ordinary General Shareholders' Meeting on June 18, 2026, Grifols, S.A. approved a mandatory preferred dividend of EUR 0.01 per Class B share and an ordinary dividend totaling EUR 56,065,663, both payable on July 2, 2026. The meeting also approved the re-election of Montserrat Muñoz Abellana and Susana González Rodríguez to the Board of Directors and the re-election of Deloitte Auditores, S.L. as statutory auditor for 2027-2029. Additionally, shareholders authorized the Board to increase share capital by up to 50% over five years, authorized a share capital reduction of up to 10% via treasury share redemption, and approved a new directors' remuneration policy for 2026-2028. One proposal regarding the calling of Extraordinary General Shareholders' Meetings failed to reach a sufficient majority. The company operates in the healthcare industry, specializing in plasma-derived medicines and diagnostics.